Related references
Note: Only part of the references are listed.NAT10 and DDX21 Proteins Interact with RNase H1 and Affect the Performance of Phosphorothioate Oligonucleotides
Lingdi Zhang et al.
NUCLEIC ACID THERAPEUTICS (2022)
Antisense oligonucleotides: absorption, distribution, metabolism, and excretion
Mohammad Shadid et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2021)
Antisense technology: A review
Stanley T. Crooke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Oligonucleotides to Pancreatic Beta Cell
Laurent Knerr et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
Drug discovery and development scheme for liver-targeting bridged nucleic acid antisense oligonucleotides
Fumito Wada et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Programmed Instability of Ligand Conjugation Manifold for Efficient Hepatocyte Delivery of Therapeutic Oligonucleotides
Chisato Terada et al.
NUCLEIC ACID THERAPEUTICS (2021)
Recent Advances in the Delivery Carriers and Chemical Conjugation Strategies for Nucleic Acid Drugs
Shota Oyama et al.
CANCERS (2021)
Systemic Brain Delivery of Antisense Oligonucleotides across the Blood-Brain Barrier with a Glucose-Coated Polymeric Nanocarrier
Hyun Su Min et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy
Diane E. Frank et al.
NEUROLOGY (2020)
Understanding the effect of controlling phosphorothioate chirality in the DNA gap on the potency and safety of gapmer antisense oligonucleotides
Michael E. Ostergaard et al.
NUCLEIC ACIDS RESEARCH (2020)
Development of Antibody-Oligonucleotide Complexes for Targeting Exosomal MicroRNA
Asako Yamayoshi et al.
PHARMACEUTICS (2020)
The Interaction of Phosphorothioate-Containing RNA Targeted Drugs with Proteins Is a Critical Determinant of the Therapeutic Effects of These Agents
Stanley T. Crooke et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
Some ASOs that bind in the coding region of mRNAs and induce RNase H1 cleavage can cause increases in the pre-mRNAs that may blunt total activity
Xue-hai Liang et al.
NUCLEIC ACIDS RESEARCH (2020)
Immunogenicity Assessment of Inotersen, a 2′-O-(2-Methoxyethyl) Antisense Oligonucleotide in Animals and Humans: Effect on Pharmacokinetics, Pharmacodynamics, and Safety
Rosie Z. Yu et al.
NUCLEIC ACID THERAPEUTICS (2020)
Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index
Wen Shen et al.
NATURE BIOTECHNOLOGY (2019)
Differential uptake, kinetics and mechanisms of intracellular trafficking of next-generation antisense oligonucleotides across human cancer cell lines
Emily Linnane et al.
NUCLEIC ACIDS RESEARCH (2019)
Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases
Maria K. Tsoumpra et al.
EBIOMEDICINE (2019)
The Pharmacokinetics of 2′-O-Methyl Phosphorothioate Antisense Oligonucleotides: Experiences from Developing Exon Skipping Therapies for Duchenne Muscular Dystrophy
Sieto Bosgra et al.
NUCLEIC ACID THERAPEUTICS (2019)
Kinetic and subcellular analysis of PS-ASO/protein interactions with P54nrb and RNase H1
Timothy A. Vickers et al.
NUCLEIC ACIDS RESEARCH (2019)
Quantitative fluorescence imaging determines the absolute number of locked nucleic acid oligonucleotides needed for suppression of target gene expression
Annette Buntz et al.
NUCLEIC ACIDS RESEARCH (2019)
Characterization of the interactions of chemically-modified therapeutic nucleic acids with plasma proteins using a fluorescence polarization assay
Hans J. Gaus et al.
NUCLEIC ACIDS RESEARCH (2019)
Identifying and avoiding off-target effects of RNase H-dependent antisense oligonucleotides in mice
Peter H. Hagedorn et al.
NUCLEIC ACIDS RESEARCH (2018)
A Sensitive In Vitro Approach to Assess the Hybridization-Dependent Toxic Potential of High Affinity Gapmer Oligonucleotides
Andreas Dieckmann et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Targeted delivery of antisense oligonucleotides to pancreatic β-cells
C. Ammala et al.
SCIENCE ADVANCES (2018)
Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides
Naoki Iwamoto et al.
NATURE BIOTECHNOLOGY (2017)
Cellular uptake and trafficking of antisense oligonucleotides
Stanley T. Crooke et al.
NATURE BIOTECHNOLOGY (2017)
Intra-endosomal trafficking mediated by lysobisphosphatidic acid contributes to intracellular release of phosphorothioate-modified antisense oligonucleotides
Shiyu Wang et al.
NUCLEIC ACIDS RESEARCH (2017)
Characterizing the effect of GalNAc and phosphorothioate backbone on binding of antisense oligonucleotides to the asialoglycoprotein receptor
Karsten Schmidt et al.
NUCLEIC ACIDS RESEARCH (2017)
Strategies for In Vivo Screening and Mitigation of Hepatotoxicity Associated with Antisense Drugs
Piotr J. Kamola et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Serial incorporation of a monovalent GalNAc phosphoramidite unit into hepatocyte-targeting antisense oligonucleotides
Tsuyoshi Yamamoto et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
The Medicinal Chemistry of Therapeutic Oligonucleotides
W. Brad Wan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2'-modifications and enhances antisense activity
Xue-Hai Liang et al.
NUCLEIC ACIDS RESEARCH (2016)
The delivery of therapeutic oligonucleotides
Rudolph L. Juliano
NUCLEIC ACIDS RESEARCH (2016)
Development of a Quantitative BRET Affinity Assay for Nucleic Acid-Protein Interactions
Timothy A. Vickers et al.
PLOS ONE (2016)
Ribonuclease H1-dependent hepatotoxicity caused by locked nucleic acid-modified gapmer antisense oligonucleotides
Takeshi Kasuya et al.
Scientific Reports (2016)
Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
Richard S. Geary et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Clinical and Preclinical Pharmacokinetics and Pharmacodynamics of Mipomersen (Kynamro®): A Second-Generation Antisense Oligonucleotide Inhibitor of Apolipoprotein B
Richard S. Geary et al.
CLINICAL PHARMACOKINETICS (2015)
Identification and characterization of intracellular proteins that bind oligonucleotides with phosphorothioate linkages
Xue-hai Liang et al.
NUCLEIC ACIDS RESEARCH (2015)
Safety and Pharmacokinetic Profiles of Phosphorodiamidate Morpholino Oligomers with Activity against Ebola Virus and Marburg Virus: Results of Two Single-Ascending-Dose Studies
Alison E. Heald et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing
Jayaprakash K. Nair et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice
Thazha P. Prakash et al.
NUCLEIC ACIDS RESEARCH (2014)
Glycomimetic Ligands for the Human Asialoglycoprotein Receptor
Sreeman K. Mamidyala et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
Sebahattin Cirak et al.
LANCET (2011)
Morpholinos and their peptide conjugates: Therapeutic promise and challenge for Duchenne muscular dystrophy
Hong M. Moulton et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2010)
Trivalent, Gal/GalNAc-containing ligands designed for the asialoglycoprotein receptor
Oleg Khorev et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Solid-Phase Synthesis of Stereoregular Oligodeoxyribonucleoside Phosphorothioates Using Bicyclic Oxazaphospholidine Derivatives as Monomer Units
Natsuhisa Oka et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Phosphorothioate oligonucleotides block the VDAC channel
Wenzhi Tan et al.
BIOPHYSICAL JOURNAL (2007)
Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate
Adams Amantana et al.
BIOCONJUGATE CHEMISTRY (2007)
Phosphorothioate oligonucleotides reduce mitochondrial outer membrane permeability to ADP
Wenzhi Tan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Pharmacokinetics and tissue distribution of a peptide nucleic acid after intravenous administration
BM McMahon et al.
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT (2002)
Share Paper
